Tag: Cyp1a2 inhibitor

Omeprazole is primarily metabolized by the cytochrome P450 system, specifically enzymes CYP2C19 and CYP3A4 [1.3.1, 1.3.3]. The question of whether **is omeprazole a CYP1A2 inhibitor** is complex, as studies show it has a dual, though weak, role as both a weak inhibitor and an inducer of this enzyme [1.2.1, 1.2.2].

Famotidine, the active ingredient in Pepcid, is primarily metabolized by the cytochrome P450 system, specifically CYP1A2 [1.2.3]. This article examines the crucial question: Is Pepcid a CYP1A2 inhibitor and what are the clinical implications?

Ciprofloxacin, a widely used fluoroquinolone antibiotic, is a potent inhibitor of the human cytochrome P450 1A2 (CYP1A2) enzyme [1.2.2]. Understanding the answer to 'Is ciprofloxacin an inducer or inhibitor?' is critical for preventing potentially dangerous drug-drug interactions.

The cytochrome P450 enzyme CYP3A4 is responsible for metabolizing about half of all drugs on the market [1.8.4]. Understanding the answer to 'Is ciprofloxacin a CYP3A4 inhibitor?' is vital for preventing serious drug interactions and ensuring patient safety.